Pacific Biosciences Of California (PACB) Other financing activities (2019 - 2026)

Pacific Biosciences Of California's Other financing activities history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Other financing activities fell 26.65% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 4.87% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, down 55.5% from the prior year.
• Other financing activities eased to $1.4 million in Q1 2026 per PACB's latest filing, from $1.5 million in the prior quarter.
• Across five years, Other financing activities topped out at $7.2 million in Q1 2023 and bottomed at $812000.0 in Q3 2024.
• The 5-year median for Other financing activities is $2.0 million (2025), against an average of $3.0 million.
• Biggest YoY gain for Other financing activities was 2373.17% in 2022; the steepest drop was 97.59% in 2022.
• Year by year, Other financing activities stood at $1.2 million in 2022, then decreased by 24.94% to $936000.0 in 2023, then dropped by 13.25% to $812000.0 in 2024, then surged by 80.91% to $1.5 million in 2025, then dropped by 2.18% to $1.4 million in 2026.
• Per Business Quant, the three latest PACB Other financing activities figures stand at $1.4 million (Q1 2026), $1.5 million (Q3 2025), and $2.0 million (Q1 2025).